Market News
- Dyne Therapeutics gets grant for patent granted for method of reducing DMPK expression in muscleby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Reduce DMPK expression in muscle cells with Dyne Therapeutics’ patented method using an anti-transferrin receptor antibody linked to an oligonucleotide. Learn more about this potential treatment for DMPK-related diseases.
- Allogene Therapeutics gets grant for patent granted for CD19-specific CARS resistant to rituximabby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover the groundbreaking patent by Allogene Therapeutics for CD19-specific CARs resistant to rituximab binding. Learn about the innovative methods and features of these engineered immune cells.
- Krystal Biotech gets grant for pharmaceutical composition for cancer treatment using recombinant HSV-1 virusby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover the groundbreaking patent by Krystal Biotech Inc for a cancer-fighting pharmaceutical composition with a recombinant HSV-1 virus encoding IL-2 and IL-12 polypeptides. Explore the innovative potential for medical treatments beyond vaccines.
- Redx Pharma gets grant for ROCK inhibitors for treating ROCK mediated diseasesby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover Redx Pharma’s groundbreaking patent for novel compounds targeting ROCK1 and ROCK2 inhibitors. Explore the unique structural features and therapeutic potential of these compounds in treating ROCK mediated diseases.
- UCB gets grant for dual-specific IL-17a and IL-17F antibody for therapyby kgi-admin (Pharmaceutical Technology) on April 23, 2024
UCB SA patent for IL-17A and IL-17F antibody molecules with expression vectors and host cell methods. Discover the innovative approach to efficient nucleic acid expression.
- Mochida Pharmaceutical gets grant for self-emulsifying preparation for enhanced EPA absorptionby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Achieve specific plasma EPA concentrations with Mochida Pharmaceutical’s self-emulsifying composition patent. Learn about the innovative encapsulation technology for improved absorbability and stability in food and pharmaceutical applications.
- Yuhan gets grant for patent granted for anti-PD-L1 IGG class antibodiesby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover how Yuhan Corp’s patent for anti-PD-L1 IgG class antibodies revolutionizes manufacturing yields. Learn about the advancements in production efficiency and potential therapeutic applications.
- Novartis gets grant for chimeric antigen receptor for T cell specificity regulationby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover Novartis AG’s groundbreaking patent for the innovative KIR-CAR, a chimeric antigen receptor revolutionizing T cell therapy. Explore the unique components and potential applications of this game-changing technology.
- Jazz Pharmaceuticals gets grant for CBD preparation with at least 90% CBD and THCby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover how Jazz Pharmaceuticals’ patented CBD preparation, with over 90% CBD and a specific THC ratio, is revolutionizing disease treatment. Explore the synergistic effects of minor impurities like THC in this groundbreaking pharmaceutical […]
- Hanmi Science gets grant for compound for binding to globulin Fc region or polypeptideby kgi-admin (Pharmaceutical Technology) on April 23, 2024
Discover the latest patent from Hanmi Science Co Ltd for a compound binding to globulin Fc region or polypeptide. Learn about the innovative methods for preparing polypeptide conjugates and more.
- Upcoming US Pharma and Biotech Summit Spotlights Innovation, Challenges in Healthcareby OncLive articles on April 23, 2024
Leaders in areas such as drug discovery, clinical development and market access will meet to discuss AI, failing life expectancy, and a new generation of talent.
- LabConnect Agrees to Acquire A4P Consultingby OncLive articles on April 23, 2024
LabConnect will utilize the consulting firm’s assets to improve its clinical trial services.
- Molecular You and Immunovia Announce Positive Results for Two Separate Pancreatic Cancer Testsby OncLive articles on April 23, 2024
The new tests are reportedly more accurate at detecting early-stage pancreatic cancer.
- Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & moreby OncLive articles on April 23, 2024
The latest news for pharma industry insiders.
- Lilly to buy injectable drug plant in manufacturing ramp-upby Delilah Alvarado (BioPharma Dive – Latest News) on April 22, 2024
The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.
- Current State of the Pharma Sales and Marketing Sales Forceby OncLive articles on April 22, 2024
Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion
- The Support of Artificial Intelligence in Biologics Production Volume: A Conversation with Alessandro Zannini, Global After-Sales Manager, Stevanato Groupby OncLive articles on April 22, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Alessandro Zannini, Global After-Sales Manager, Stevanato Group discusses the benefits of generative artificial intelligence.
- Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseasesby Delilah Alvarado (BioPharma Dive – Latest News) on April 22, 2024
The deal, which could be worth up to $1.8 billion, is the latest research collaboration involving small molecule drugs that modify RNA.
- Eisai hunts for next Alzheimer’s drug with new research pactby Jonathan Gardner (BioPharma Dive – Latest News) on April 22, 2024
A collaboration with BioArctic will focus on a technology designed to more effectively deliver drugs in the brain, following similar efforts by Roche.
- Bristol Myers taps startup to boost cell therapy productionby Ned Pagliarulo (BioPharma Dive – Latest News) on April 22, 2024
A partnership with Cellares, worth up to $380 million, is meant to help Bristol Myers speed and scale manufacture of CAR-T treatments for cancer.